Deal Snapshot
ESSA PHARMA TO ACQUIRE REALM THERAPEUTICS IN USD 20.5M STOCK DEAL
Tuesday 21 May 2019

Canada-based pharmaceutical company ESSA Pharma Inc. (NASDAQ: EPIX) (TSX Venture: EPI) has agreed to acquire all issued and outstanding shares of Pennsylvania, US-based biopharmaceutical company Realm Therapeutics plc (NASDAQ: RLM) in an all-stock transaction, the company said.
The acquisition is intended to be implemented by means of a United Kingdom Court-sanctioned scheme of arrangement under Part 26 of the UK Companies Act 2006 and is expected to be completed by mid-year 2019.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 21/05/2019
Target: Realm Therapeutics
Country: USA
Deal Size: 20.5m (USD)
Sector: Pharmaceuticals
Type: Corporate acquisition
Financing: Stock
Status: Agreed
Vendor:
Buyer: ESSA Pharma
Buyer Advisor: Oppenheimer and Co , Eversheds Sutherland , Blake Cassels and Graydon , Skadden, Arps, Slate, Meagher and Flom
Comment:


Options